Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammation
Biotech
AbbVie pays $48M for OSE's preclinical chronic inflammation drug
AbbVie handed OSE the upfront fee and dangled another $665 million in milestones for global rights to a novel approach to chronic inflammation.
Nick Paul Taylor
Feb 28, 2024 5:25am
AstraZeneca axes IL-33 kidney disease program after seeing data
Feb 8, 2024 5:30am
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 1:06pm
Aiolos Bio launches with $245M to advance severe asthma med
Oct 24, 2023 7:00am
Revolo drops dab of midphase data on would-be Dupixent rival
Apr 19, 2023 9:30am
Aristea closes shop over safety signals from inflammation drug
Feb 10, 2023 10:25am